BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanno A, Satoh K, Hirota M, Hamada S, Umino J, Itoh H, Masamune A, Asakura T, Shimosegawa T. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol. 2010;45:952-959. [PMID: 20383536 DOI: 10.1007/s00535-010-0238-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Tobaly D, Santinha J, Sartoris R, Dioguardi Burgio M, Matos C, Cros J, Couvelard A, Rebours V, Sauvanet A, Ronot M, Papanikolaou N, Vilgrain V. CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Cancers (Basel) 2020;12:E3089. [PMID: 33114028 DOI: 10.3390/cancers12113089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Mori Y, Ohtsuka T, Tamura K, Ideno N, Aso T, Kono H, Nagayoshi Y, Ueda J, Takahata S, Aishima S, Ookubo F, Oda Y, Tanaka M. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy. Surgery 2014;155:67-73. [DOI: 10.1016/j.surg.2013.06.059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Lee T, Kim HJ, Park SK, Yang HJ, Jung YS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Choi KY. Natural courses of branch duct intraductal papillary mucinous neoplasm. Langenbecks Arch Surg 2017;402:429-37. [PMID: 28255733 DOI: 10.1007/s00423-017-1565-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Sahora K, Mino-Kenudson M, Brugge W, Thayer SP, Ferrone CR, Sahani D, Pitman MB, Warshaw AL, Lillemoe KD, Fernandez-del Castillo CF. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg 2013;258:466-75. [PMID: 24022439 DOI: 10.1097/SLA.0b013e3182a18f48] [Cited by in Crossref: 191] [Cited by in F6Publishing: 74] [Article Influence: 21.2] [Reference Citation Analysis]
5 Kobayashi G, Fujita N, Maguchi H, Tanno S, Mizuno N, Hanada K, Hatori T, Sadakari Y, Yamaguchi T, Tobita K, Doi R, Yanagisawa A, Tanaka M; Working Group for the Natural History of IPMN of the Japan Pancreas Society. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study. Pancreas 2014;43:532-8. [PMID: 24717801 DOI: 10.1097/MPA.0000000000000080] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
6 Ammori JB, Do RK, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. J Gastrointest Surg 2014;18:911-6. [PMID: 24448998 DOI: 10.1007/s11605-014-2449-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
7 Budde C, Beyer G, Kühn JP, Lerch MM, Mayerle J. The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices. Viszeralmedizin 2015;31:47-52. [PMID: 26286668 DOI: 10.1159/000375455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Daudé M, Muscari F, Buscail C, Carrère N, Otal P, Selves J, Buscail L, Bournet B. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastroenterol 2015; 21(9): 2658-2667 [PMID: 25759534 DOI: 10.3748/wjg.v21.i9.2658] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
9 Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas – epidemiology, risk factors, diagnosis, and management. Scandinavian Journal of Gastroenterology 2017;52:803-15. [DOI: 10.1080/00365521.2017.1318948] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
10 Jana T, Shroff J, Bhutani MS. Pancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management options. J Carcinog. 2015;14:3. [PMID: 25821410 DOI: 10.4103/1477-3163.153285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
11 Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, Mckay C, Friess H, Manfredi R, Van Cutsem E, Löhr M, Segersvärd R, Abakken L, Adham M, Albin N, Andren-sandberg Å, Arnelo U, Bruno M, Cahen D, Cappelli C, Costamagna G, Del Chiaro M, Delle Fave G, Esposito I, Falconi M, Friess H, Ghaneh P, Gladhaug I, Haas S, Hauge T, Izbicki J, Klöppel G, Lerch M, Lundell L, Lüttges J, Löhr M, Manfredi R, Mayerle J, Mckay C, Oppong K, Pukitis A, Rangelova E, Rosch T, Salvia R, Schulick R, Segersvärd R, Sufferlein T, Van Cutsem E, Van der Merwe S, Verbeke C, Werner J, Zamboni G. European experts consensus statement on cystic tumours of the pancreas. Digestive and Liver Disease 2013;45:703-11. [DOI: 10.1016/j.dld.2013.01.010] [Cited by in Crossref: 286] [Cited by in F6Publishing: 234] [Article Influence: 31.8] [Reference Citation Analysis]
12 Maguchi H, Tanno S. Natural History and Malignant Transformation of Branch Duct IPMN. In: Tanaka M, editor. Intraductal Papillary Mucinous Neoplasm of the Pancreas. Tokyo: Springer Japan; 2014. pp. 19-26. [DOI: 10.1007/978-4-431-54472-2_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Kawakami S, Fukasawa M, Shimizu T, Ichikawa S, Sato T, Takano S, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Hayakawa H, Nakayama Y, Yamaguchi T, Inoue T, Maekawa S, Kawaida H, Motosugi U, Onishi H, Enomoto N. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm. Medicine (Baltimore) 2019;98:e18039. [PMID: 31764824 DOI: 10.1097/MD.0000000000018039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Tanaka M. Intraductal Papillary Mucinous Neoplasm as the Focus for Early Detection of Pancreatic Cancer. Gastroenterology. 2018;154:475-478. [PMID: 29337154 DOI: 10.1053/j.gastro.2018.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Wu W, Hong X, Tian R, You L, Dai M, Liao Q, Zhang T, Zhao Y. An increased total resected lymph node count benefits survival following pancreas invasive intraductal papillary mucinous neoplasms resection: an analysis using the surveillance, epidemiology, and end result registry database. PLoS One 2014;9:e107962. [PMID: 25264746 DOI: 10.1371/journal.pone.0107962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Sahora K, Fernández-del Castillo C, Dong F, Marchegiani G, Thayer SP, Ferrone CR, Sahani DV, Brugge WR, Warshaw AL, Lillemoe KD, Mino-Kenudson M. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery 2014;156:611-21. [PMID: 25081232 DOI: 10.1016/j.surg.2014.04.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
17 Efthymiou A, Podas T, Zacharakis E. Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms. World J Gastroenterol 2014; 20(24): 7785-7793 [PMID: 24976716 DOI: 10.3748/wjg.v20.i24.7785] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
18 Kobayashi N, Sugimori K, Shimamura T, Hosono K, Watanabe S, Kato S, Ueda M, Endo I, Inayama Y, Maeda S. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12:141-145. [PMID: 22487524 DOI: 10.1016/j.pan.2011.12.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
19 Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:824-48.e22. [PMID: 25805376 DOI: 10.1053/j.gastro.2015.01.014] [Cited by in Crossref: 208] [Cited by in F6Publishing: 161] [Article Influence: 29.7] [Reference Citation Analysis]
20 Zhou W, Xu Y, Rong Y, Wu W, Kuang T, Xin B, Zhu H, Lou W, Wang D. Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms. J Surg Oncol 2018;117:409-16. [DOI: 10.1002/jso.24882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
21 Rezaee N, Khalifian S, Cameron JL, Pawlik TM, Hruban RH, Fishman EK, Makary MA, Lennon AM, Wolfgang CL, Weiss MJ. Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms. J Gastrointest Surg 2015;19:656-65. [PMID: 25477314 DOI: 10.1007/s11605-014-2714-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
22 Xiao SY. Intraductal papillary mucinous neoplasm of the pancreas: an update. Scientifica (Cairo) 2012;2012:893632. [PMID: 24278753 DOI: 10.6064/2012/893632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
23 Tanaka M. Clinical Management and Surgical Decision-Making of IPMN of the Pancreas. In: Su GH, editor. Pancreatic Cancer. New York: Springer; 2019. pp. 9-22. [DOI: 10.1007/978-1-4939-8879-2_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
24 Hanada K, Amano H, Abe T. Early diagnosis of pancreatic cancer: Current trends and concerns. Ann Gastroenterol Surg 2017;1:44-51. [PMID: 29863166 DOI: 10.1002/ags3.12004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
25 Mori Y, Ohtsuka T, Kono H, Ideno N, Aso T, Nagayoshi Y, Takahata S, Nakamura M, Ishigami K, Aishima S, Oda Y, Tanaka M. Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012;41:1008-12. [PMID: 22850621 DOI: 10.1097/MPA.0b013e31824b22c6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
26 Hirono S, Shimizu Y, Ohtsuka T, Kin T, Hara K, Kanno A, Koshita S, Hanada K, Kitano M, Inoue H, Itoi T, Ueki T, Shimokawa T, Hijioka S, Yanagisawa A, Nakamura M, Okazaki K, Yamaue H. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society. J Gastroenterol. 2020;55:86-99. [PMID: 31463655 DOI: 10.1007/s00535-019-01617-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
27 Sahora K, Crippa S, Zamboni G, Ferrone C, Warshaw A, Lillemoe K, Mino-kenudson M, Falconi M, Fernandez-del Castillo C. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. European Journal of Surgical Oncology (EJSO) 2016;42:197-204. [DOI: 10.1016/j.ejso.2015.10.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
28 Lensing RJ, Bipat S. Incidences of Pancreatic Malignancy and Mortality in Patients With Untreated Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Surveillance: A Systematic Review. Pancreas. 2017;46:1098-1110. [PMID: 28902778 DOI: 10.1097/mpa.0000000000000907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Björk Werner J, Bartosch-härlid A, Andersson R. Cystic pancreatic lesions: Current evidence for diagnosis and treatment. Scandinavian Journal of Gastroenterology 2011;46:773-88. [DOI: 10.3109/00365521.2011.551892] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
30 Buerlein RCD, Shami VM. Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know. Ther Adv Gastrointest Endosc 2021;14:26317745211045769. [PMID: 34589706 DOI: 10.1177/26317745211045769] [Reference Citation Analysis]
31 Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kijima Y, Ishigami S, Ueno S, Shinchi H, Natsugoe S. Predictors of early stages of histological progression of branch duct IPMN. Langenbecks Arch Surg 2015;400:49-56. [DOI: 10.1007/s00423-014-1259-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol. 2011;8:56-60. [PMID: 21212775 DOI: 10.1038/nrgastro.2010.193] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
33 Nguyen AH, Toste PA, Farrell JJ, Clerkin BM, Williams J, Muthusamy VR, Watson RR, Tomlinson JS, Hines OJ, Reber HA, Donahue TR. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg 2015;19:258-65. [PMID: 25373706 DOI: 10.1007/s11605-014-2693-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
34 Fujita M, Itoi T, Ikeuchi N, Sofuni A, Tsuchiya T, Ishii K, Kamada K, Umeda J, Tanaka R, Tonozuka R, Honjo M, Mukai S, Moriyasu F. Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions. Endosc Ultrasound. 2016;5:377-383. [PMID: 28000629 DOI: 10.4103/2303-9027.190927] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
35 van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, van Hooft JE, Besselink MG. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol. 2019;16:676-689. [PMID: 31527862 DOI: 10.1038/s41575-019-0195-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 13.7] [Reference Citation Analysis]
36 Kimura K, Amano R, Ymazoe S, Ohira G, Nishio K, Hirakawa K, Ohira M. The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the Pancreas. World J Surg 2017;41:1358-65. [DOI: 10.1007/s00268-016-3824-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Bournet B, Vignolle-Vidoni A, Grand D, Roques C, Breibach F, Cros J, Muscari F, Carrère N, Selves J, Cordelier P, Buscail L. Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas. Endosc Int Open 2016;4:E1228-35. [PMID: 27995180 DOI: 10.1055/s-0042-117216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
38 Abue M, Yokoyama M, Shibuya R, Tamai K, Yamaguchi K, Sato I, Tanaka N, Hamada S, Shimosegawa T, Sugamura K, Satoh K. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. Int J Oncol. 2015;46:539-547. [PMID: 25384963 DOI: 10.3892/ijo.2014.2743] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 12.5] [Reference Citation Analysis]
39 Akimoto Y, Nouso K, Kato H, Miyahara K, Dohi C, Morimoto Y, Kinugasa H, Tomoda T, Yamamoto N, Tsutsumi K, Kuwaki K, Onishi H, Ikeda F, Nakamura S, Shiraha H, Takaki A, Okada H, Amano M, Nishimura S, Yamamoto K. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreatology 2015;15:432-8. [DOI: 10.1016/j.pan.2015.05.470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
40 Ideno N, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Tamura K, Aso T, Aishima S, Miyasaka Y, Ohuchida K, Ueda J, Takahata S, Oda Y, Mizumoto K, Tanaka M. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas 2015;44:311-20. [PMID: 25479586 DOI: 10.1097/MPA.0000000000000258] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
41 Hamada S, Shimosegawa T. Biomarkers of Pancreatic Cancer. Pancreatology 2011;11:14-9. [DOI: 10.1159/000323479] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
42 Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang J, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97. [DOI: 10.1016/j.pan.2012.04.004] [Cited by in Crossref: 1540] [Cited by in F6Publishing: 1233] [Article Influence: 154.0] [Reference Citation Analysis]
43 Haruki K, Wakiyama S, Futagawa Y, Shiba H, Misawa T, Yanaga K. A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report. Surg Case Rep 2015;1:20. [PMID: 26943388 DOI: 10.1186/s40792-014-0009-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Tanaka M. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma. Pancreas. 2018;47:544-550. [PMID: 29702531 DOI: 10.1097/mpa.0000000000001047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
45 Hata T, Mizuma M, Motoi F, Ishida M, Morikawa T, Nakagawa K, Hayashi H, Kanno A, Masamune A, Kamei T, Naitoh T, Furukawa T, Unno M. An integrated analysis of host- and tumor-derived markers for predicting high-grade dysplasia and associated invasive carcinoma of intraductal papillary mucinous neoplasms of the pancreas. Surg Today 2020;50:1039-48. [PMID: 32124086 DOI: 10.1007/s00595-020-01982-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Kang KM, Lee JM, Shin CI, Baek JH, Kim SH, Yoon JH, Han JK, Choi BI. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. J Magn Reson Imaging. 2013;38:555-563. [PMID: 23390008 DOI: 10.1002/jmri.24022] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
47 Mayerle J, Kraft M, Menges P, Simon P, Ringel J, Partecke LI, Heidecke CD, Lerch MM. [Intraductal papillary mucinous neoplasia: which findings support observation?]. Chirurg. 2012;83:123-129. [PMID: 22271054 DOI: 10.1007/s00104-011-2183-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Komatsu S, Ichikawa D, Miyamae M, Kawaguchi T, Morimura R, Hirajima S, Okajima W, Ohashi T, Imamura T, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Taniguchi H, Otsuji E. Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma. Expert Opin Biol Ther. 2015;15:773-785. [PMID: 25819175 DOI: 10.1517/14712598.2015.1029914] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
50 Park RHS, Lim GRS, Wu JJY, Koh YX, Teo JY, Cheow PC, Chan CY, Ooi LLPJ, Chung AYF, Goh BKP. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients. Eur J Surg Oncol 2020;46:2114-21. [PMID: 32828582 DOI: 10.1016/j.ejso.2020.07.027] [Reference Citation Analysis]
51 Tanaka M. International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas. Ann Transl Med 2015;3:286. [PMID: 26697446 DOI: 10.3978/j.issn.2305-5839.2015.11.09] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
52 Piraka C, Scheiman JM. New diagnostic imaging modalities for pancreatic disease. Curr Opin Gastroenterol 2011;27:475-80. [PMID: 21743318 DOI: 10.1097/MOG.0b013e328349e30c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Mandai K, Uno K, Yasuda K. Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm: a report of 8 cases. Clin J Gastroenterol 2013;6:248-54. [DOI: 10.1007/s12328-013-0386-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
54 Hoshi H, Zaheer A, El Abiad RG, Maxwell JE, Chu LC, Gerke H, Chan CH. Management of pancreatic intraductal papillary mucinous neoplasm. Current Problems in Surgery 2018;55:126-52. [DOI: 10.1067/j.cpsurg.2018.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Tomishima K, Sai JK, Kanazawa R, Miura H, Shimizu R, Sato K, Ishii S, Saito H, Ito T, Fukumura Y, Shiina S, Watanabe S. Impact of MUC1 Expression on the Progression of Intraductal Papillary Mucinous Neoplasm With Worrisome Features During Follow-up. Pancreas 2017;46:1127-32. [DOI: 10.1097/mpa.0000000000000902] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
56 Shah R, Mulki R, Lamm V, Kapil N, Patel V, Chawla S, Cai Q, Willingham FF, Keilin S. Prevalence and Risk Factors for Intraductal Papillary Mucinous Neoplasm in Patients With Chronic Kidney Disease: A Single-Center Case-Control Study. Pancreas 2021;50:327-9. [PMID: 33835962 DOI: 10.1097/MPA.0000000000001752] [Reference Citation Analysis]
57 Koh YX, Zheng HL, Chok AY, Tan CS, Wyone W, Lim TK, Tan DM, Goh BK. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms. Surgery. 2015;157:496-509. [PMID: 25656693 DOI: 10.1016/j.surg.2014.08.098] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
58 Sultana A, Jackson R, Tim G, Bostock E, Psarelli EE, Cox TF, Sutton R, Ghaneh P, Raraty MG, Neoptolemos JP, Halloran CM. What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses. Clin Transl Gastroenterol 2015;6:e130. [PMID: 26658837 DOI: 10.1038/ctg.2015.60] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
59 Lee KH, Lee SJ, Lee JK, Ryu JK, Kim EY, Kim TH, Moon JH, Lee WJ, Cho YK, Kim JJ. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm. Pancreas 2014;43:1306-11. [PMID: 25036913 DOI: 10.1097/MPA.0000000000000177] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
60 Kang JS, Park T, Han Y, Lee S, Lim H, Kim H, Kim SH, Kwon W, Kim SW, Jang JY. Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas. Ann Surg Treat Res. 2019;97:58-64. [PMID: 31388508 DOI: 10.4174/astr.2019.97.2.58] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
61 Matsubayashi H, Ishiwatari H, Sasaki K, Uesaka K, Ono H. Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Gut Liver. 2020;14:30-36. [PMID: 31009958 DOI: 10.5009/gnl18491] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
62 Tanaka M. Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas. Dig Endosc 2015;27:450-7. [PMID: 25588761 DOI: 10.1111/den.12434] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
63 Hsiao CY, Yang CY, Wu JM, Kuo TC, Tien YW. Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: A single-center experience with 138 surgically treated patients. Medicine (Baltimore) 2016;95:e4922. [PMID: 27661043 DOI: 10.1097/MD.0000000000004922] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
64 Abel L, Wasserthal J, Weikert T, Sauter AW, Nesic I, Obradovic M, Yang S, Manneck S, Glessgen C, Ospel JM, Stieltjes B, Boll DT, Friebe B. Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning. Diagnostics (Basel) 2021;11:901. [PMID: 34069328 DOI: 10.3390/diagnostics11050901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]